Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Cyanobacteriota

ABSTRACT: Genome Sequencing Project of the NIES cyanobacteria collection 2016

PROVIDER: PRJDB5665 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other
	DRR315816_1.fastq.gz	Fastqsanger.gz
	DRR315816_2.fastq.gz	Fastqsanger.gz
	DRR315817_1.fastq.gz	Fastqsanger.gz
	DRR315817_2.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 142

Similar Datasets

Cyanobacteriota

Project description:Genome sequencing Cyanobacteria cultures of the Culture Collection of Algae & Protozoa (CCAP)

| PRJNA1127564 | ENA

Cyanobacteriota

Project description:cyanobacterial genomes in NIES

| PRJDB7814 | ENA

Cyanobacteriota

Project description:Cyanobacteria overview

| PRJNA187002 | ENA

Cyanobacteriota

Project description:Comparison between GT and SigE overexpressed strains of cyanobacteria

| PRJNA137269 | ENA

Cyanobacteriota

Project description:Cyanobacteriota Genome sequencing and assembly

| PRJNA616171 | ENA

Cyanobacteriota

Project description:Cyanobacteriota Genome sequencing and assembly

| PRJNA448332 | ENA

RNA-seq of Chara braunii NIES 1604 and S276

Project description:To investigate gene expression in different cells of Chara braunii we performed RNA sequencing of whole thali with rhizoids and thalli without rhizoids in strains NIES 1604 and S276.

2025-09-30 | GSE275253 | GEO

Cyanobacteria

Project description:Collection of cyanobacteria at NWU, South Africa

| PRJNA680469 | ENA

A multicenter translational biomarker phase II trial of regorafenib in patients with non-resectable pretreated colorectal cancer.

Project description:Primary objectives: The primary objective is to investigate circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS). Primary endpoints: circulating tumor DNA (ctDNA) via deep sequencing for mutation detection and by whole genome sequencing for copy number analyses before start (baseline) with regorafenib and at defined time points during administration of regorafenib for treatment efficacy in colorectal cancer patients in terms of overall survival (OS).

| 2533916 | ecrin-mdr-crc

Project description:Genomes from the Australian National Cyanobacteria Reference Collection

| PRJNA924361 | ENA